RESEARCH TRIANGLE PARK – The Triangle has landed another corporate headquarters – ventilator manufacturer IPM Chirana.
The firm also has begun production of its devices at a facility in Boston operated by technology firm SMTC.
“These milestones are part of our mission to improve healthcare outcomes by providing clinicians around the world with cutting edge, patient-centric solutions like the Aura V ICU ventilator,” said Bud Reeves, the firm’s CEO, in the announcement. “We are very excited to establish our headquarters in the prestigious Research Triangle Park area. Furthermore, we are proud of SMTC’s accomplishment of implementing our accelerated production plan and are proceeding to manufacture at least 300 Aura V ventilators by year-end.”
An Aura V ventilator. IPM Chirana image
The Aura device is designed for use in intensive care units. Demand for ventilators has soared during the global COVIDA-19 pandemic.
“The Aura V ventilator is one of the most technologically advanced critical care ventilators in the world,” said Mike Gentile, Vice President of Medical Affairs, in a statement. “With the ongoing COVID-19 pandemic and a worldwide shortage, our contribution to the global production of ICU ventilators is crucial. Many more patients and clinicians will benefit from the Aura V ventilator’s sophisticated, unique technology that optimizes patient care.”
IPM is the result of a partnership between European companies IPM Group and Chirana Medical.
The company notes that applications for use of the ventilators in the U.S. and Canada are currently in review and have been available in Europe.
Its corporate address is listed as 4601 Creekstone Drive, Suite 170 Durham, NC 27703
